SCHEMBL526342

SCHEMBL526342

Cc1ccc(Oc2ccc([C@@H](O)[C@H](CCn3nnc4ccccc4c3=O)C(=O)O)cc2F)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 10/20 0.47
NPSR1 Q6W5P4 2/20 0.44
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
MMP9 P14780 1/20 0.42
MMP13 P45452 1/20 0.42
KDM4E B2RXH2 2/20 0.42
KMT2A Q03164 1/20 0.42
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL529547 0.91 GPR139 (0.41) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL530605 0.91 NPC1 (0.46) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL530606 0.91 NPC1 (0.46) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL526592 0.89 NPC1 (0.43) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL526083 0.84 NPC1 (0.54) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL528362 0.84 GPR139 (0.50) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL528363 0.84 GPR139 (0.50) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL527807 0.83 MMP1 (0.46) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL527806 0.83 MMP1 (0.46) GPR139NPSR1MMP1MMP2MMP3
SCHEMBL526247 0.82 NPSR1 (0.50) GPR139NPSR1MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598493-A1 MATRIX METALLOPROTEINASE INHIBITORS Ranbaxy Laboratories Limited (IN) 2013-06-05 EP claimed
WO-2012014114-A1 MATRIX METALLOPROTEINASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2012-02-02 WO claimed